Acer Therapeutics to Present at the Evercore ISI HealthConX Conference
NEWTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical …